Strong Teens for Healthy Schools Change Club: A Civic Engagement Approach to Improving Physical Activity and Healthy Eating Environments

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8+
SponsorTexas A&M University

About this trial

Strong Teens for Healthy Schools (STHS) is a school-based, civic engagement program that empowers middle school students to improve their physical activity and healthy eating behaviors, improve their cardiovascular disease outcomes, and create positive change in their school health environments.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

> 50 6th and 7th grade students

> 40% economically disadvantaged students

> 40% Black and Hispanic students

Disqualifiers

6th or 7th grade student

Attend a Title 1 middle school that is participating in the STHS intervention

Read and understand English

Participation in a weight loss program in the past 3 months

Trial design

Design model

Parallel

Treatments tested in this trial

  • STHS Intervention

    Behavioral

    STHS program The intervention group (10 schools) will participate in the STHS program. During the fall semester (September to December), the intervention group will receive 24 thirty-minute modules (or twelve 1-hour modules) that provide education on civic engagement, healthy eating, and physical activity. During the spring semester (February to May), the intervention group will receive 24 thirty-minute modules (or twelve 1-hour modules) that focus on implementing the school health environmental change project and receive support for maintaining individual-level healthy eating and physical activity behaviors.

  • Usual Care

    Behavioral

    No STHS program The usual care group will be offered the same activities as the intervention group after the conclusion of the research study.

Treatment groups

500 Participants
are divided into 2 treatment groups
Group A: STHS InterventionExperimental treatment 1 intervention
Group B: Usual CareOther 1 intervention

Trial outcomes

Primary outcomes

1

Presence or absence of metabolic syndrome (MetS)

MetS is present after identifying abdominal obesity plus at least two of the four other MetS Risk factors: high blood pressure, high blood sugar, low HDL cholesterol, and high triglyceride levels. MetS = (abdominal obesity) + (2 of 4 other MetS Risk factors) Measures to determine MetS risk factors: 1. Abdominal obesity: waist circumference \>90th percentile for child's sex and age 2. High blood pressure: systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥90 mmHg) 3. High blood glucose: blood glucose ≥5.6 mmol/L or known diabetes 4. Low HDL cholesterol: HDL cholesterol \<1.03 mmol/L 5. High triglyceride level: Triglyceride level ≥ 1.7mmol/L

Time frame
Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention
2

Change in the number of MetS risk factors

Change in the number of MetS risk factors = (new # of MetS risk factors) - (original # of MetS risk factors) Measures to determine MetS risk factors: 1. Abdominal obesity: waist circumference \>90th percentile for child's sex and age 2. High blood pressure: systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥90 mmHg) 3. High blood glucose: blood glucose ≥5.6 mmol/L or known diabetes 4. Low HDL cholesterol: HDL cholesterol \<1.03 mmol/L 5. High triglyceride level: Triglyceride level ≥ 1.7mmol/L

Time frame
Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention
3

Positive Youth Development score

Positive youth development will be measured using a 5 C's Model of Positive Youth Development Scale-Short Form (PYD-SF): A 34-item scale that assesses the strength of psychological, behavioral, and social development in youth. The five dimensions measured are: 1. Competence (sense of proficiency) 2. Confidence (self-worth, self-efficacy) 3. Character (adherence to societal and cultural rules) 4. Connection (bonds with people and institutions) 5. Caring (sympathy and empathy towards others)

Time frame
Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention

Secondary outcomes

1

Blood pressure level

Blood pressure (systolic and diastolic) will be measured with two numbers using an automated Omron sphygmomanometer.

Time frame
Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention
2

Concentration of blood glucose

Glucose will be measured using a portable Cholestech LDX analyzer to assess a single capillary blood sample following an overnight fast.

Time frame
Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention
3

Waist circumference

Waist circumference will be measured at the midpoint between the floating rib and iliac crest using a tape measure.

Time frame
Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention
4

Concentration of HDL cholesterol

HDL-C will be measured using a portable Cholestech LDX analyzer to assess a single capillary blood sample following an overnight fast.

Time frame
Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Texas A&M University

Lead sponsor

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator